Adding to further pain is that Trump is talking about tariffs on imported pharma meaning that even if they get this illusive contract with the VA it won’t be as profitable as previously thought. The only hope is that this is distressed selling which often happens at bottoms right before the company turns around, only hoping now. I wonder if Bell Potter who were the brokers still have a buy rating and target of $1.20? Now that there is dilution and they set the SPP at 42.5c which was also overpriced according to the markets valuation. I’m wondering if there was a cap raise written on the wall as AF was saying that a cap raise was unlikely needed, only a few months before you guessed it, was actually needed. He’s either clueless about the operation of the company, or he was lying.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)